Aspect Magnet Technologies and Bruker BioSpin Corporation Establish a Collaborative Effort in Developing 1 Tesla Desktop MRI Solutions for New Preclinical MRI Applications

BEN SHEMEN, Israel & ETTLINGEN, Germany--(BUSINESS WIRE)--At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the development of a high performance desktop preclinical MRI system. The new MRI scanner will benefit from the combination of Aspect’s innovative 1 Tesla (T) permanent magnet system and Bruker BioSpin’s high-performance MRI spectrometer technology and its routine preclinical software package.